Analysis Estimates Up To 2 Million Uninsured People Could Require COVID-19 Hospitalization April 7, 2020 News Release Patients Could Still Be on the Hook for Outpatient Costs, Costs If They Test Negative, and Cost Sharing A new KFF analysis estimates that between 670,000 and 2 million uninsured people around the country eventually could be hospitalized with COVID-19, the respiratory disease caused by the novel coronavirus. Reimbursing hospitals…
Estimated Cost of Treating the Uninsured Hospitalized with COVID-19 April 7, 2020 Issue Brief This brief estimates the total amount that will be spent to reimburse hospitals for care for the uninsured with COVID-19, the disease caused by the coronavirus.
Comparing Private Payer and Medicare Payment Rates for Select Inpatient Hospital Services July 7, 2020 Issue Brief This issue brief analyzes hospital payments paid by private payers and by Medicare for a selection of inpatient services, including services requiring similar inpatient treatments to those used for COVID-19. It finds that private insurance payments for such services vary widely and exceed Medicare payment levels.
Where are the COVID-19 Hotspots? Tracking State Outbreaks June 30, 2020 Issue Brief This brief analyzes multiple COVID-19 metrics to determine which states the pandemic is moving in the wrong, or right, direction as an increasing number of cases could be the result of more testing or the result of increasing transmission, or a combination of both.
Medicare Accelerated and Advance Payments for COVID-19 Revenue Loss: More Time to Repay October 8, 2020 Issue Brief This brief provides an overview and status update of the Medicare accelerated and advance payment program, which provided $100 billion in loans to Medicare providers in the spring of 2020 to compensate for revenue shortfalls due to the coronavirus pandemic. The brief describes who got the funds, and how these loans are distinct from other funds that providers received, which do not have to be repaid.
The Cost of Inpatient and Outpatient Care Drives High Health Spending in the U.S. Relative to Other Countries, New Analysis Finds October 1, 2020 News Release A new KFF issue brief compares the main drivers of health spending in the United States and other large, wealthy countries, and finds that the cost of inpatient and outpatient care – much more so than prescription drugs or administrative costs – drives high per capita health spending in the U.S.…
Drugs Aren’t the Reason the U.S. Spends So Much on Health Care September 30, 2020 Perspective Drew Altman’s column in Axios: the U.S. now spends twice per capita what other wealthy countries do on health care. But while drug costs get all the time in public debate, it’s hospital and outpatient spending that mostly explains the difference. And that will be impossible to take on without real pain and political risk, he says.
COVID-19 Test Prices and Payment Policy April 29, 2021 Issue Brief This analysis examines list prices for COVID-19 testing at the largest hospitals in every state and finds they range widely from $20 to $850. Federal law now requires private insurers to cover COVID-19 tests at no cost to the patient and provides funding for people without health insurance.
How Could the Price of Remdesivir Impact Medicare Spending for COVID-19 Patients? July 14, 2020 Issue Brief This brief discusses how drugs provided in inpatient hospital settings are covered and reimbursed for beneficiaries in traditional Medicare under current law. This is relevant for Medicare spending on COVID-19 patients who receive Gilead’s new antiviral drug remdesivir. We discuss the implications for hospitals and the Medicare program of spending on remdesivir.
Update on COVID-19 Funding for Hospitals and Other Providers April 24, 2020 Blog This blog is an overview of the outstanding questions related to the $100 billion for hospitals and other providers in the CARES Act and whether there will be meaningful protections for the uninsured and people with private coverage who could face surprise bills.